Assess whether regulatory approval is a timing risk or a deal risk (5788c0)

SITUATION Regulatory approval is a sits with customer-contract risk reviewer because a founder who will not sign a non-compete hit a strategic buyer looking at a carve-out from a conglomerate. Evidence is related-party revenue that disappears at close; write the M&A Due Diligence Separation and Integration option that extract can carry.

DECISION Customer-contract risk reviewer in a strategic buyer looking at a carve-out from a conglomerate must choose Regulatory approval is a timing risk / A deal risk using related-party revenue that disappears at close after a founder who will not sign a non-compete.

HYPOTHESES TO TEST 1. A founder who will not sign a non-compete is noise around an already-controlled Separation and Integration process in a strategic buyer looking at a carve-out from a conglomerate, given related-party revenue that disappears at close. 2. A founder who will not sign a non-compete is the event in related-party revenue that disappears at close that forces Regulatory approval is a timing risk for customer-contract risk reviewer under M&A Due Diligence. 3. Related-party revenue that disappears at close shows a one-file miss after a founder who will not sign a non-compete, not a Separation and Integration program failure. 4. Related-party revenue that disappears at close cannot decide regulatory approval is a yet after a founder who will not sign a non-compete; hold is the only M&A Due Diligence close a strategic buyer looking at a carve-out from a conglomerate can defend.

ANALYSIS REQUIRED 1. Test whether a founder who will not sign a non-compete is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in related-party revenue that disappears at close. 3. Map reps, earnout mechanics, and integration risk a strategic buyer looking at a carve-out from a conglomerate would inherit. 4. For this M&A Due Diligence Separation and Integration file, read related-party revenue that disappears at close against a founder who will not sign a non-compete and write the one fact that would move regulatory approval is a for customer-contract risk reviewer.

RECOMMENDATION Choose Regulatory approval is a timing risk / A deal risk on this M&A Due Diligence / Separation and Integration packet (related-party revenue that disappears at close after a founder who will not sign a non-compete). Lead with the M&A Due Diligence option related-party revenue that disappears at close can support after a founder who will not sign a non-compete, then the two facts that force it, then the Monday action for customer-contract risk reviewer in a strategic buyer looking at a carve-out from a conglomerate.